Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP774912.RAUCto3ngN2PUbQVQFFIuQNUUibF1cypEbcCtvLdoRBT8130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP774912.RAUCto3ngN2PUbQVQFFIuQNUUibF1cypEbcCtvLdoRBT8130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP774912.RAUCto3ngN2PUbQVQFFIuQNUUibF1cypEbcCtvLdoRBT8130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP774912.RAUCto3ngN2PUbQVQFFIuQNUUibF1cypEbcCtvLdoRBT8130_provenance.
- NP774912.RAUCto3ngN2PUbQVQFFIuQNUUibF1cypEbcCtvLdoRBT8130_assertion wasGeneratedBy ECO_0000203 NP774912.RAUCto3ngN2PUbQVQFFIuQNUUibF1cypEbcCtvLdoRBT8130_provenance.
- NP774912.RAUCto3ngN2PUbQVQFFIuQNUUibF1cypEbcCtvLdoRBT8130_assertion wasDerivedFrom befree-20140225 NP774912.RAUCto3ngN2PUbQVQFFIuQNUUibF1cypEbcCtvLdoRBT8130_provenance.
- NP774912.RAUCto3ngN2PUbQVQFFIuQNUUibF1cypEbcCtvLdoRBT8130_assertion SIO_000772 12434133 NP774912.RAUCto3ngN2PUbQVQFFIuQNUUibF1cypEbcCtvLdoRBT8130_provenance.
- NP774912.RAUCto3ngN2PUbQVQFFIuQNUUibF1cypEbcCtvLdoRBT8130_assertion evidence source_evidence_literature NP774912.RAUCto3ngN2PUbQVQFFIuQNUUibF1cypEbcCtvLdoRBT8130_provenance.
- NP774912.RAUCto3ngN2PUbQVQFFIuQNUUibF1cypEbcCtvLdoRBT8130_assertion description "[It was shown that, in NSCLC: (1) tumor stroma inflammatory cells are mainly TIL (approximately 2/3) (among them, 80 % are T-cells) and TAM (approximately 1/3), with almost no natural killer (NK) cells, and a few dentritic cells; (2) TAM and TIL are poorly replicating, but mainly recruited to the tumor stroma; (3) more than half TAM show an antibody-dependent cytotoxic potential, and one third of T-cells are TIA-1 positive CD8 activated cytotoxic lymphocytes; (4) cancer cells from only a few tumor express HLA class I and II antigens; (5) TAM production of cytotoxic cytokines [interleukin-1alpha (IL-1alpha), IL-1beta, IL-6, tumor necrosis factor-alpha (TNF-alpha)] and of transforming growth factor-beta1 (TGF-beta1) is low, in contrast to their strong release of platelet-derived growth factor (PDGF).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP774912.RAUCto3ngN2PUbQVQFFIuQNUUibF1cypEbcCtvLdoRBT8130_provenance.
- befree-20140225 importedOn "2014-02-25" NP774912.RAUCto3ngN2PUbQVQFFIuQNUUibF1cypEbcCtvLdoRBT8130_provenance.